NRXP NRX PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Securities Purchase Agreement and Certificate of Designation NRX Pharmaceuticals, Inc. entered into a securities purchase agreement, issuing 3,000,000 shares of Series A Convertible Preferred Stock and one investor warrant for every share, with aggregate proceeds of $1.2 million. The company also filed a Certificate of Designation authorizing up to 12,000,000 shares of Series A Convertible Preferred Stock.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC